The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease.

about

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease.

Item

http://www.wikidata.org/entity/Q45354626

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

The Longitudinal Study of Live ...... and Polycystic Liver Disease.

@en

The Longitudinal Study of Live ...... and Polycystic Liver Disease.

@nl

type

Item

label

The Longitudinal Study of Live ...... and Polycystic Liver Disease.

@en

The Longitudinal Study of Live ...... and Polycystic Liver Disease.

@nl

prefLabel

The Longitudinal Study of Live ...... and Polycystic Liver Disease.

@en

The Longitudinal Study of Live ...... and Polycystic Liver Disease.

@nl

P1476

The Longitudinal Study of Live ...... e and Polycystic Liver Disease

@en

P2093

Kenjiro Honda

http://www.w3.org/2001/XMLSchema#string

Kent Doi

http://www.w3.org/2001/XMLSchema#string

Masaomi Nangaku

http://www.w3.org/2001/XMLSchema#string

Ryo Matsuura

http://www.w3.org/2001/XMLSchema#string

Yoshifumi Hamasaki

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

Evidence-based clinical practice guidelines for polycystic kidney disease 2014

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Polycystic liver diseases: advanced insights into the molecular mechanisms

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide.

Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma.

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Liver involvement in early autosomal-dominant polycystic kidney disease

P304

60-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EKIR.2016.09.061

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eisei Noiri

P577

2016-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29142941

http://www.w3.org/2001/XMLSchema#string

P921

autosomal dominant polycystic kidney disease

P932

5678648

http://www.w3.org/2001/XMLSchema#string